Scaffold-Free Tubular Engineered Heart Tissue From Human Induced Pluripotent Stem Cells Using Bio-3D Printing Technology in vivo

Engineered heart tissues (EHTs) that are fabricated using human induced pluripotent stem cells (hiPSCs) have been considered as potential cardiac tissue substitutes in case of heart failure. In the present study, we have created hiPSC-derived cardiac organoids (hiPSC-COs) comprised of hiPSC-derived cardiomyocytes, human umbilical vein endothelial cells, and human fibroblasts. To produce a beating conduit for patients suffering from congenital heart diseases, we constructed scaffold-free tubular EHTs (T-EHTs) using hiPSC-COs and bio-3D printing with needle arrays. The bio-3D printed T-EHTs were cut open and transplanted around the abdominal aorta as well as the inferior vena cava (IVC) of NOG mice. The transplanted T-EHTs were covered with the omentum, and the abdomen was closed after completion of the procedure. Additionally, to compare the functionality of hiPSC-COs with that of T-EHTs, we transplanted the former around the aorta and IVC as well as injecting them into the subcutaneous tissue on the back of the mice. After 1 m of the transplantation procedures, we observed the beating of the T-EHTs in the mice. In histological analysis, the T-EHTs showed clear striation of the myocardium and vascularization compared to hiPSC-COs transplanted around the aorta or in subcutaneous tissue. Based on these results, bio-3D-printed T-EHTs exhibited a better maturation in vivo as compared to the hiPSC-COs. Therefore, these beating T-EHTs may form conduits for congenital heart disease patients, and T-EHT transplantation can form a treatment option in such cases.

[1]  Y. Tabata,et al.  Intramyocardial Transplantation of Human iPS Cell–Derived Cardiac Spheroids Improves Cardiac Function in Heart Failure Animals , 2021, JACC. Basic to translational science.

[2]  K. Fukuda,et al.  Tryptophan Metabolism Regulates Proliferative Capacity of Human Pluripotent Stem Cells , 2021, iScience.

[3]  K. Nakayama,et al.  Fabrication of Cardiac Constructs Using Bio-3D Printer. , 2021, Methods in molecular biology.

[4]  M. Itoh,et al.  Drug response analysis for scaffold-free cardiac constructs fabricated using bio-3D printer , 2020, Scientific Reports.

[5]  Tatsuya Shimizu,et al.  Engineering of functional cardiac tubes by stepwise transplantation of cardiac cell sheets onto intestinal mesentery , 2020, Heart and Vessels.

[6]  Tatsuya Shimizu,et al.  Pulsatile tubular cardiac tissues fabricated by wrapping human iPS cells-derived cardiomyocyte sheets , 2019, Regenerative therapy.

[7]  S. Toda,et al.  Development of an immunodeficient pig model allowing long-term accommodation of artificial human vascular tubes , 2019, Nature Communications.

[8]  Y. Tabata,et al.  Development of a transplant injection device for optimal distribution and retention of human induced pluripotent stem cell‒derived cardiomyocytes. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[9]  M. Itoh,et al.  Fabrication of scaffold-free tubular cardiac constructs using a Bio-3D printer , 2018, PloS one.

[10]  Keiichi Fukuda,et al.  Efficient Large-Scale 2D Culture System for Human Induced Pluripotent Stem Cells and Differentiated Cardiomyocytes , 2017, Stem cell reports.

[11]  Takashi Daimon,et al.  Enhanced Therapeutic Effects of Human iPS Cell Derived-Cardiomyocyte by Combined Cell-Sheets with Omental Flap Technique in Porcine Ischemic Cardiomyopathy Model , 2017, Scientific Reports.

[12]  N. Hibino,et al.  Biomaterial-Free Three-Dimensional Bioprinting of Cardiac Tissue using Human Induced Pluripotent Stem Cell Derived Cardiomyocytes , 2017, Scientific Reports.

[13]  Lil Pabon,et al.  Mechanical Stress Conditioning and Electrical Stimulation Promote Contractility and Force Maturation of Induced Pluripotent Stem Cell-Derived Human Cardiac Tissue , 2016, Circulation.

[14]  Herbert Schulz,et al.  Human Engineered Heart Tissue: Analysis of Contractile Force , 2016, Stem cell reports.

[15]  M. Suematsu,et al.  Glutamine Oxidation Is Indispensable for Survival of Human Pluripotent Stem Cells. , 2016, Cell metabolism.

[16]  M. Itoh,et al.  Development of a three-dimensional pre-vascularized scaffold-free contractile cardiac patch for treating heart disease. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  K. Boheler,et al.  Physical developmental cues for the maturation of human pluripotent stem cell-derived cardiomyocytes , 2014, Stem Cell Research & Therapy.

[18]  S. Miyagawa,et al.  Present and Future Perspectives on Cell Sheet-Based Myocardial Regeneration Therapy , 2013, BioMed research international.

[19]  T. Okano,et al.  Enhanced Survival of Transplanted Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes by the Combination of Cell Sheets With the Pedicled Omental Flap Technique in a Porcine Heart , 2013, Circulation.

[20]  M. Suematsu,et al.  Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. , 2013, Cell stem cell.

[21]  Tatsuya Shimizu,et al.  Enhanced Survival of Transplanted Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes by the Combination of Cell Sheets With the Pedicled Omental Flap Technique in a Porcine Heart , 2013 .

[22]  A. Pant,et al.  The Anti-Inflammatory and Antibacterial Basis of Human Omental Defense: Selective Expression of Cytokines and Antimicrobial Peptides , 2011, PloS one.

[23]  Teruo Okano,et al.  Pulsatile Myocardial Tubes Fabricated With Cell Sheet Engineering , 2006, Circulation.